Many studies have demonstrated that CDR1as is expressed abnormally in many cancer types (Pan et al., 2018; Su et al., 2018; Tanaka et al., 2019; Lin et al., 2020; Tian et al., 2020; Zhou et al., 2020). This evidence concerns the gene LINC00632 and cancer.